Literature DB >> 16419495

Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.

L G Rao1, T M Murray, J N Wylie, R J McBroom, M Kung Sutherland.   

Abstract

We have shown that osteoblastic cells derived from trabecular bone explants of osteoporotic subjects (OP cells) exhibited an altered alkaline phosphatase (ALP) response to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] compared to control (CON) cells. Our hypothesis that OP cells have other intrinsic abnormalities was investigated using our cell models representing two different stages of differentiation. OP and CON cells were cultured in the absence (-DEX) or presence (+DEX) of 10 nM dexamethasone (DEX) in 10% fetal calf serum (FCS) prior to exposure to serum-free medium containing 1 nM of PTH and/or 17-beta estradiol (E2). Both OP and CON cells responded to DEX with a two-fold increase in basal ALP activity. While E2 or PTH+E2 had no effect on OP cells, both treatments inhibited ALP activity in CON cells (p<0.05). OP and CON cells grown in DEX also expressed PTH-stimulated adenylate cyclase (AC) activities higher than those of (-DEX) cells. OP+DEX cells, however, exhibited activities which were 8-fold higher than those of CON+DEX cells (p<0.001). In OP+DEX cells, E2 stimulated basal AC activity (p<0.05) but did not affect PTH-stimulated activity. In contrast, in CON+DEX cells, E2 had no effect on basal activity but inhibited PTH-stimulated AC activity (p<0.001). Osteocalcin production was 4-fold lower in OP+DEX cells compared to OP-DEX and CON cells (p<0.05) while osteocalcin mRNA levels were significantly lower in OP+DEX and CON+/-DEX cells compared to OP-DEX cells (p<0.05). E2 did not affect osteocalcin protein or mRNA levels in either OP or CON cells. No differences in mRNA levels were found for estrogen receptor-alpha (ER-a) in OP+/-DEX cells whereas these levels were significantly higher in CON+DEX compared to CON-DEX cells (p<0.05). These results indicate that DEX amplified the differences between OP and CON cells and confirm the presence of intrinsic osteoblastic abnormalities in patients with osteoporosis that persist in culture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419495     DOI: 10.1007/bf03345324

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  58 in total

1.  Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor.

Authors:  R L Horst; J P Goff; T A Reinhardt
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

2.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain.

Authors:  H Shimizu; J W Daly; C R Creveling
Journal:  J Neurochem       Date:  1969-12       Impact factor: 5.372

4.  Estrogen-induced resistance to osteoblast apoptosis is associated with increased hsp27 expression.

Authors:  L F Cooper; J C Tiffee; J P Griffin; H Hamano; Z Guo
Journal:  J Cell Physiol       Date:  2000-12       Impact factor: 6.384

Review 5.  Osteoporosis: current approaches and future prospects in diagnosis, pathogenesis, and management.

Authors:  L G Raisz
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

6.  Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: evidence that skeletal sensitivity is increased.

Authors:  M A Kotowicz; G G Klee; P C Kao; W M O'Fallon; S F Hodgson; S L Cedel; E F Eriksen; D G Gonchoroff; H L Judd; B L Riggs
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.

Authors:  M Subramaniam; D Colvard; P E Keeting; K Rasmussen; B L Riggs; T C Spelsberg
Journal:  J Cell Biochem       Date:  1992-12       Impact factor: 4.429

9.  1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.

Authors:  R J Duda; R Kumar; K I Nelson; A R Zinsmeister; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls.

Authors:  M M Wong; L G Rao; H Ly; L Hamilton; S Ish-Shalom; W Sturtridge; J Tong; R McBroom; R G Josse; T M Murray
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

View more
  1 in total

1.  Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.

Authors:  N Maruotti; A Corrado; M Grano; S Colucci; F P Cantatore
Journal:  Rheumatol Int       Date:  2008-11-07       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.